Decreased biochemical progression in patients with castration-resistant prostate cancer using a novel mefenamic acid anti-inflammatory therapy: A randomized controlled trial

Prostate cancer (PCa) is the second most common non-dermatological cancer in men and is a growing public health problem. Castration-resistant disease (CRD) is the most advanced stage of the disease and is difficult to control. Patients with CRD may no longer accept conventional therapies as they are...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncol Lett
Main Authors: Guzman-Esquivel, José, Mendoza-Hernandez, Martha A., Tiburcio-Jimenez, Daniel, Avila-Zamora, Oscar N., Delgado-Enciso, Josuel, De-Leon-Zaragoza, Luis, Casarez-Price, Juan C., Rodriguez-Sanchez, Iram P., Martinez-Fierro, Margarita L., Meza-Robles, Carmen, Barocio-Acosta, Alejandro, Baltazar-Rodriguez, Luz M., Zaizar-Fregoso, Sergio A., Plata-Florenzano, Jorge E., Delgado-Enciso, Iván
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2020
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204620/
https://ncbi.nlm.nih.gov/pubmed/32391109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11509
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker